IT202200007811A1 - Nuova composizione per l’uso nel trattamento di ferite - Google Patents

Nuova composizione per l’uso nel trattamento di ferite Download PDF

Info

Publication number
IT202200007811A1
IT202200007811A1 IT102022000007811A IT202200007811A IT202200007811A1 IT 202200007811 A1 IT202200007811 A1 IT 202200007811A1 IT 102022000007811 A IT102022000007811 A IT 102022000007811A IT 202200007811 A IT202200007811 A IT 202200007811A IT 202200007811 A1 IT202200007811 A1 IT 202200007811A1
Authority
IT
Italy
Prior art keywords
wounds
treatment
new composition
composition
new
Prior art date
Application number
IT102022000007811A
Other languages
English (en)
Inventor
Danilo Riva
Alberto Laffranchi
Gloria Pumilia
Alice Lerose
Original Assignee
Ind Farmaceutica Nova Argentia S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Farmaceutica Nova Argentia S P A filed Critical Ind Farmaceutica Nova Argentia S P A
Priority to IT102022000007811A priority Critical patent/IT202200007811A1/it
Priority to EP23165396.5A priority patent/EP4265245A1/en
Publication of IT202200007811A1 publication Critical patent/IT202200007811A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
IT102022000007811A 2022-04-20 2022-04-20 Nuova composizione per l’uso nel trattamento di ferite IT202200007811A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT102022000007811A IT202200007811A1 (it) 2022-04-20 2022-04-20 Nuova composizione per l’uso nel trattamento di ferite
EP23165396.5A EP4265245A1 (en) 2022-04-20 2023-03-30 New composition for use in the treatment of wounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102022000007811A IT202200007811A1 (it) 2022-04-20 2022-04-20 Nuova composizione per l’uso nel trattamento di ferite

Publications (1)

Publication Number Publication Date
IT202200007811A1 true IT202200007811A1 (it) 2023-10-20

Family

ID=82608729

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102022000007811A IT202200007811A1 (it) 2022-04-20 2022-04-20 Nuova composizione per l’uso nel trattamento di ferite

Country Status (2)

Country Link
EP (1) EP4265245A1 (it)
IT (1) IT202200007811A1 (it)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070265352A1 (en) * 2002-02-19 2007-11-15 Joachim Roeding Synergistic mixtures of at least one 1,2 alkanediol such as 1,2-hexanediol and 1,2-octanediol with a further compound having antimicrobial properties
US20150150908A1 (en) * 2013-12-03 2015-06-04 Team Unlimited, LLC Compositions and methods for treating skin wounds
WO2021176410A1 (en) 2020-03-05 2021-09-10 Industria Farmaceutica Nova Argentia S.R.L. Hemostatic agent
US20220008371A1 (en) * 2013-06-10 2022-01-13 Naeem Uddin Broad spectrum pharmacological composition for treatment of various infections and diseases and methods of use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070265352A1 (en) * 2002-02-19 2007-11-15 Joachim Roeding Synergistic mixtures of at least one 1,2 alkanediol such as 1,2-hexanediol and 1,2-octanediol with a further compound having antimicrobial properties
US20220008371A1 (en) * 2013-06-10 2022-01-13 Naeem Uddin Broad spectrum pharmacological composition for treatment of various infections and diseases and methods of use
US20150150908A1 (en) * 2013-12-03 2015-06-04 Team Unlimited, LLC Compositions and methods for treating skin wounds
WO2021176410A1 (en) 2020-03-05 2021-09-10 Industria Farmaceutica Nova Argentia S.R.L. Hemostatic agent

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "KAQUN GEL, KAQUN", THERAPEUTICS UPDATE, May 2019 (2019-05-01), pages 63 - 64, XP093003695, Retrieved from the Internet <URL:https://practicaldermatology.com/articles/2019-may/new-productsnew-in-my-practice-otc-1/pdf> [retrieved on 20221130] *
B. S. NAGOBA ET AL: "Microbiological, histopathological and clinical changes in chronic infected wounds after citric acid treatment", JOURNAL OF MEDICAL MICROBIOLOGY, vol. 57, no. 5, May 2008 (2008-05-01), pages 681 - 682, XP055310593, ISSN: 0022-2615, DOI: 10.1099/jmm.0.47647-0 *
NAGOBA B S ET AL: "CITRIC ACID TREATMENT OF SEVERE ELECTRIC BURNS COMPLICATED BY MULTIPLE ANTIBIOTIC RESISTANT PSEUDOMONAS AERUGINOSA", BURNS, BUTTERWORTH HEINEMANN, GB, vol. 24, no. 5, August 1998 (1998-08-01), pages 481 - 483, XP001080463, ISSN: 0305-4179, DOI: 10.1016/S0305-4179(98)00052-7 *
PATHAK ET AL.: "Dermatology in general medicines", 1987, MC GRAW HILL, article "Preventive treatment of sunburn, dermatoheliosis and skin cancer with agents", pages: 1507 - 1592

Also Published As

Publication number Publication date
EP4265245A1 (en) 2023-10-25

Similar Documents

Publication Publication Date Title
NI201900062A (es) Compuestos de amino-triazolopiridina y su uso en el tratamiento del cáncer
NI202000099A (es) Compuestos de purinona y su uso en el tratamiento del cáncer
CL2015002658A1 (es) Derivados de 2, 3 - disustituto 1- acil -4 amino - 1,2,3,4 tetrahidroquinilina y su uso como inhibidores de bromodominio
CL2011003266A1 (es) Compuestos derivados de imidazolidin-2-ona, con actividad inhibidora de 17alfa-hidroxilasa/liasa-c17,20; composicion farmaceutica que los comprende; y uso en el tratamiento de inflamacion o cancer, entre otras.
UY29796A1 (es) Nuevos compuestos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor
CL2007001996A1 (es) Compuestos derivados de heteroarilos nitrogenados sustituidos con fenilo, inhibidores de la produccion de citoquinas; composicion farmaceutica que los comprende; y sus usos en el tratamiento del cancer, infecciones, enfermedades inflamatorias y autoinmunes.
UY31017A1 (es) Uso de un inhibidor del factor &amp;(alfa) de necrosis tumoral mas un antihistaminico para el tratamiento de la rinitis alérgica y la conjuntivitis alérgica.
CL2008001756A1 (es) Agente de arn de interferencia (iarn); composicion farmaceutica que lo comprende; y su uso para tratar procesos patologicos mediados al menos en parte por la expresion del canal de sodio epitelial alfa (alfa-enac)
BR112018012177A2 (pt) ?moduladores de hidantação de canais kv 3?
BR112017026294A2 (pt) formulação em gel tópica farmacêutica, e, método para tratar ou prevenir uma doença ou condição.
CL2021001044A1 (es) Uso de plasma y fracciones de plasma para mejorar el dolor, la cicatrización de heridas y la recuperación posoperatoria
BR112015026247A8 (pt) composto em combinação com um análogo de citidina, composição farmacêutica que os compreende, uso dos mesmos e kit
CL2008002545A1 (es) Compuestos derivados de fenoxi-bencil-carbamoilo; composicion farmaceutica; procedimiento para preparar la composicion farmaceutica; y su uso en el tratamiento del dolor.
CL2008000202A1 (es) Compuestos derivados de n-aril-acetamida, antagonista trpv1;composicion farmaceutica que los comprende, utiles en el tratamiento del dolor.
UY35344A (es) Oestra-1,3,5(10),16-tetraeno-3-carboxamidas
BR112015026388A2 (pt) métodos e composições para cicatrização de feridas
BR112014031706A8 (pt) Composições farmacêuticas orais, e composição farmacêutica oral compreendendo itraconazol
IT201900021564A1 (it) Composizione nutraceutica o farmaceutica comprendente ferro pirofosfato per l’uso nel trattamento e/o nella prevenzione di condizioni o patologie caratterizzate da carenza di ferro
IT201700025666A1 (it) Composizione per l’uso nel trattamento dell’ipercolesterolemia e nella prevenzione di patologie cardiovascolari.
IT202200007811A1 (it) Nuova composizione per l’uso nel trattamento di ferite
IT201700089258A1 (it) Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
IT201700085412A1 (it) Composizione per uso nella prevenzione e nel trattamento di patologie dell&#39;apparato cardiovascolare
CL2019002260A1 (es) Composición antiséptica que comprende unitiol y dimetilulfóxido, uso de la composición y método de tratamiento de heridas con su uso.
BR112019017314A2 (pt) composições farmacêuticas para terapia de combinação
CL2022000067A1 (es) Composiciones para el tratamiento de la pérdida del cabello